G101D (p.Gly101Asp) variant of APP (Amyloid-beta precursor protein)

G101D (p.Gly101Asp) in APP (Amyloid-beta precursor protein) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Alzheimer disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.62 / 1. The record also includes population frequency data, published literature, and structural context.

G101D (p.Gly101Asp) variant details